drugset / Trial / NCT05970744
Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of the study is to investigate the safety and immunogenicity of the RSV/Flu-01E vaccine for the prevention of respiratory syncytial virus infection in volunteers aged18 to 59 years and over 60 years.
Timeline
- Start
- 2023-05-10
- Primary completion
- 2023-06-19
- Completion
- 2023-09-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RSV/Flu-01E | Vaccine | 7.7 unknown | Intranasal |
| Subject | RSV/Flu-01E | Vaccine | 8.4 unknown | Intranasal |